Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Mouse Galectin-9 Antibody, R&D Systems™

Rat Monoclonal Antibody
Supplier: R&D Systems MAB3535SP
This item is not returnable.
View return policy
Description
Galectin-9 Monoclonal specifically detects Galectin-9 in Mouse samples. It is validated for Immunohistochemistry, Intracellular Staining by Flow Cytometry, CyTOF-ready.Specifications
Galectin-9 | |
Monoclonal | |
LYOPH | |
Immunohistochemistry 8-25 ug/mL, Intracellular Staining by Flow Cytometry 2.5 ug/10^6 cells, CyTOF-ready | |
O08573-2 | |
LGALS9 | |
E. coli-derived recombinant mouse Galectin-9 (short isoform) Ala2-Thr322 Accession # O08573-2 | |
25 μg | |
Primary | |
Detects mouse Galectin-9 in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human Galectin-9 or recombinant mouse Galectin-4 is observed. | |
Mouse | |
Purified |
Immunohistochemistry, Flow Cytometry, CyTOF | |
766428 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
ecalectin, gal-9, GAL9, galectin 9, galectin-9, Galectin9, HUAT, lectin, galactoside-binding, soluble, 9, LGALS9, LGALS9A, MGC117375, MGC125973, MGC125974, Tumor antigen HOM-HD-21, urate transporter/channel protein | |
Rat | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
3965 | |
Sterile PBS to a final concentration of 0.5 mg/mL. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG2b |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction